{
    "2020-04-17": [
        [
            {
                "time": "2020-03-15",
                "original_text": "In a Pandemic, Pharmaâ€™s Strengths Emerge: Pipelines With Essential Drugs",
                "features": {
                    "keywords": [
                        "Pandemic",
                        "Pharma",
                        "Strengths",
                        "Pipelines",
                        "Essential Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "Incyte, Novartis launch drug study to treat coronavirus complication",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Novartis",
                        "drug study",
                        "coronavirus",
                        "complication"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-05-20",
                "original_text": "European stocks climb on hopes over coronavirus drug treatment",
                "features": {
                    "keywords": [
                        "European stocks",
                        "climb",
                        "hopes",
                        "coronavirus",
                        "drug treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}